Medicare Part D Redesign Could Expand Rebate-Driven Formulary Exclusions In Program

Increased application of utilization management controls expected as plans face higher costs under the redesign. However, the formulary advantages available to drugs in the protected classes may lead developers to sharpen their focus on those categories.

Formulary Exclusions Less Common In Part D Than The Commercial Market • Source: Shutterstock

More from Market Access

More from Pink Sheet